Risk of a Second Primary Cancer after Non-melanoma Skin Cancer in White Men and Women: A Prospective Cohort Study

PLoS Medicine

Volumn 10, Issue 4, 2013, Pages

  Song, Fengju ^a,b   Qureshi, Abrar A ^b   Giovannucci, Edward L ^b,c   Fuchs, Charlie S ^b,d   Chen, Wendy Y ^b,d   Stampfer, Meir J ^b,c,d   Han, Jiali ^a,b,c  

^a TIANJIN MEDICAL UNIVERSITY   (China)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^d DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER RISK; COHORT ANALYSIS; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HEALTH CARE PERSONNEL; HUMAN; MAJOR CLINICAL STUDY; MALE; NON MELANOMA SKIN CANCER; PROSPECTIVE STUDY; QUESTIONNAIRE; RISK FACTOR; SECOND CANCER;

AGED; BREAST NEOPLASMS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; INCIDENCE; LUNG NEOPLASMS; MALE; MELANOMA; MIDDLE AGED; NEOPLASMS, SECOND PRIMARY; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK FACTORS; SEX FACTORS; SKIN NEOPLASMS;

EID: 84876901760     PISSN: 15491277     EISSN: 15491676     Source Type: Journal    
DOI: 10.1371/journal.pmed.1001433     Document Type: Article

References (50)

1. Rogers HW, Weinstock MA, Harris AR, Hinckley MR, Feldman SR, et al. (2010) Incidence estimate of nonmelanoma skin cancer in the United States, 2006. Arch Dermatol 146: 283-287.
2. Lewis KG, Weinstock MA, (2007) Trends in nonmelanoma skin cancer mortality rates in the United States, 1969 through 2000. J Invest Dermatol 127: 2323-2327.
3. Chen JG, Fleischer AB Jr, Smith ED, Kancler C, Goldman ND, et al. (2001) Cost of nonmelanoma skin cancer treatment in the United States. Dermatol Surg 27: 1035-1038.
4. Frisch M, Hjalgrim H, Olsen JH, Melbye M, (1996) Risk for subsequent cancer after diagnosis of basal-cell carcinoma. A population-based, epidemiologic study. Ann Intern Med 125: 815-821.
5. Hemminki K, Dong C, (2000) Subsequent cancers after in situ and invasive squamous cell carcinoma of the skin. Arch Dermatol 136: 647-651.
6. Milan T, Pukkala E, Verkasalo PK, Kaprio J, Jansen CT, et al. (2000) Subsequent primary cancers after basal-cell carcinoma: a nationwide study in Finland from 1953 to 1995. Int J Cancer 87: 283-288.
7. Frisch M, Melbye M, (1995) New primary cancers after squamous cell skin cancer. Am J Epidemiol 141: 916-922.
8. Wassberg C, Thorn M, Yuen J, Ringborg U, Hakulinen T, (1999) Second primary cancers in patients with squamous cell carcinoma of the skin: a population-based study in Sweden. Int J Cancer 80: 511-515.
9. Troyanova P, Danon S, Ivanova T, (2002) Nonmelanoma skin cancers and risk of subsequent malignancies: a cancer registry-based study in Bulgaria. Neoplasma 49: 81-85.
10. Nugent Z, Demers AA, Wiseman MC, Mihalcioiu C, Kliewer EV, (2005) Risk of second primary cancer and death following a diagnosis of nonmelanoma skin cancer. Cancer Epidemiol Biomarkers Prev 14: 2584-2590.
11. Chen J, Ruczinski I, Jorgensen TJ, Yenokyan G, Yao Y, et al. (2008) Nonmelanoma skin cancer and risk for subsequent malignancy. J Natl Cancer Inst 100: 1215-1222.
12. Garland CF, Garland FC, Gorham ED, Lipkin M, Newmark H, et al. (2006) The role of vitamin D in cancer prevention. Am J Public Health 96: 252-261.
13. Colditz GA, Martin P, Stampfer MJ, Willett WC, Sampson L, et al. (1986) Validation of questionnaire information on risk factors and disease outcomes in a prospective cohort study of women. Am J Epidemiol 123: 894-900.
14. Hunter DJ, Colditz GA, Stampfer MJ, Rosner B, Willett WC, et al. (1990) Risk factors for basal cell carcinoma in a prospective cohort of women. Ann Epidemiol 1: 13-23.
15. Qureshi AA, Laden F, Colditz GA, Hunter DJ, (2008) Geographic variation and risk of skin cancer in US women. Differences between melanoma, squamous cell carcinoma, and basal cell carcinoma. Arch Intern Med 168: 501-507.
16. Wheless L, Black J, Alberg AJ, (2010) Nonmelanoma skin cancer and the risk of second primary cancers: a systematic review. Cancer Epidemiol Biomarkers Prev 19: 1686-1695.
17. Tuohimaa P, Pukkala E, Scelo G, Olsen JH, Brewster DH, et al. (2007) Does solar exposure, as indicated by the non-melanoma skin cancers, protect from solid cancers: vitamin D as a possible explanation. Eur J Cancer 43: 1701-1712.
18. Grant WB, (2009) Re: Nonmelanoma skin cancer and risk for subsequent malignancy. J Natl Cancer Inst 101: 210; author reply 210-211.
19. Ma Y, Zhang P, Wang F, Yang J, Liu Z, et al. (2011) Association between vitamin D and risk of colorectal cancer: a systematic review of prospective studies. J Clin Oncol 29: 3775-3782.
20. Kahn HS, Tatham LM, Patel AV, Thun MJ, Heath CW Jr, (1998) Increased cancer mortality following a history of nonmelanoma skin cancer. JAMA 280: 910-912.
21. Royle JA, Baade PD, Joske D, Girschik J, Fritschi L, (2011) Second cancer incidence and cancer mortality among chronic lymphocytic leukaemia patients: a population-based study. Br J Cancer 105: 1076-1081.
22. Hemminki K, Jiang Y, Steineck G, (2003) Skin cancer and non-Hodgkin's lymphoma as second malignancies. markers of impaired immune function? Eur J Cancer 39: 223-229.
23. Leigh IM, Newton Bishop JA, Kripke ML, (1996) Skin cancer. Introduction. Cancer Surv 26: 1-6.
24. Kripke ML, (1994) Ultraviolet radiation and immunology: something new under the sun-presidential address. Cancer Res 54: 6102-6105.
25. English DR, Armstrong BK, Kricker A, Fleming C, (1997) Sunlight and cancer. Cancer Causes Control 8: 271-283.
26. Frankel S, Gunnell DJ, Peters TJ, Maynard M, Davey Smith G, (1998) Childhood energy intake and adult mortality from cancer: the Boyd Orr Cohort Study. Bmj 316: 499-504.
27. Spitz MR, Tilley BC, Batsakis JG, Gibeau JM, Newell GR, (1984) Risk factors for major salivary gland carcinoma. A case-comparison study. Cancer 54: 1854-1859.
28. Au WW, Wilkinson GS, Tyring SK, Legator MS, el Zein R, et al. (1996) Monitoring populations for DNA repair deficiency and for cancer susceptibility. Environ Health Perspect 104 Suppl 3: 579-584.
29. Stacey SN, Sulem P, Jonasdottir A, Masson G, Gudmundsson J, et al. (2011) A germline variant in the TP53 polyadenylation signal confers cancer susceptibility. Nat Genet 43: 1098-1103.
30. Rastogi RP, Richa, Kumar A, Tyagi MB, Sinha RP, (2010) Molecular mechanisms of ultraviolet radiation-induced DNA damage and repair. J Nucleic Acids 2010: 592980.
31. Berwick M, Vineis P, (2000) Markers of DNA repair and susceptibility to cancer in humans: an epidemiologic review. J Natl Cancer Inst 92: 874-897.
32. Wei Q, Matanoski GM, Farmer ER, Hedayati MA, Grossman L, (1993) DNA repair and aging in basal cell carcinoma: a molecular epidemiology study. Proc Natl Acad Sci U S A 90: 1614-1618.
33. Grossman L, Wei Q, (1995) DNA repair and epidemiology of basal cell carcinoma. Clin Chem 41: 1854-1863.
34. Li C, Wang LE, Wei Q, (2009) DNA repair phenotype and cancer susceptibility-a mini review. Int J Cancer 124: 999-1007.
35. Mitchell D, Paniker L, Godar D, (2012) Nucleotide excision repair is reduced in oral epithelial tissues compared with skin. Photochem Photobiol 88: 1027-1032.
36. Gospodinov A, Ivanov R, Anachkova B, Russev G, (2003) Nucleotide excision repair rates in rat tissues. Eur J Biochem 270: 1000-1005.
37. Welcsh PL, Schubert EL, King MC, (1998) Inherited breast cancer: an emerging picture. Clin Genet 54: 447-458.
38. Scully R, Livingston DM, (2000) In search of the tumour-suppressor functions of BRCA1 and BRCA2. Nature 408: 429-432.
39. Kitagishi Y, Kobayashi M, Matsuda S, (2012) Defective DNA repair systems and the development of breast and prostate cancer (Review). Int J Oncol.
40. Finn OJ, (2012) Immuno-oncology: understanding the function and dysfunction of the immune system in cancer. Ann Oncol 23 Suppl 8: viii6-9.
41. Cramer DW, Finn OJ, (2011) Epidemiologic perspective on immune-surveillance in cancer. Curr Opin Immunol 23: 265-271.
42. Beissert S, Schwarz T, (1999) Mechanisms involved in ultraviolet light-induced immunosuppression. J Investig Dermatol Symp Proc 4: 61-64.
43. Narayanan DL, Saladi RN, Fox JL, (2010) Ultraviolet radiation and skin cancer. Int J Dermatol 49: 978-986.
44. Welsh MM, Karagas MR, Applebaum KM, Spencer SK, Perry AE, et al. (2008) A role for ultraviolet radiation immunosuppression in non-melanoma skin cancer as evidenced by gene-environment interactions. Carcinogenesis 29: 1950-1954.
45. Murphy GM, (2009) Ultraviolet radiation and immunosuppression. Br J Dermatol 161 Suppl 3: 90-95.
46. Schwarz T, Schwarz A, (2011) Molecular mechanisms of ultraviolet radiation-induced immunosuppression. Eur J Cell Biol 90: 560-564.
47. de Gruijl FR, (2008) UV-induced immunosuppression in the balance. Photochem Photobiol 84: 2-9.
48. van Dam RM, Huang Z, Rimm EB, Weinstock MA, Spiegelman D, et al. (1999) Risk factors for basal cell carcinoma of the skin in men: results from the health professionals follow-up study. Am J Epidemiol 150: 459-468.
49. Han J, Colditz GA, Hunter DJ, (2006) Risk factors for skin cancers: a nested case-control study within the Nurses' Health Study. Int J Epidemiol 35: 1514-1521.
50. Nan H, Xu M, Kraft P, Qureshi AA, Chen C, et al. (2011) Genome-wide association study identifies novel alleles associated with risk of cutaneous basal cell carcinoma and squamous cell carcinoma. Hum Mol Genet 20: 3718-3724.